FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

387167001: Orphenadrine citrate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1461345016 Orphenadrine citrate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481275015 Orphenadrine citrate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1461345016 Orphenadrine citrate (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1461345016 Orphenadrine citrate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481275015 Orphenadrine citrate en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1481275015 Orphenadrine citrate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5244101000241110 citrate d'orphénadrine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
5244101000241110 citrate d'orphénadrine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Orphenadrine citrate Is a Orphenadrine (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Orphenadrine citrate Has disposition Muscarinic receptor antagonist true Inferred relationship Existential restriction modifier (core metadata concept)
Orphenadrine citrate Has disposition N-methyl-D-aspartate receptor antagonist (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Orphenadrine citrate Is a Centrally acting muscle relaxant (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Orphenadrine citrate Is a Antiparkinsonian agent (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Orphenadrine citrate Is a NMDA receptor antagonist true Inferred relationship Existential restriction modifier (core metadata concept)
Orphenadrine citrate Is a Muscarinic receptor antagonist true Inferred relationship Existential restriction modifier (core metadata concept)
Orphenadrine citrate Is modification of (attribute) Orphenadrine (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Orphenadrine citrate Is a Acetylcholine receptor antagonist false Inferred relationship Existential restriction modifier (core metadata concept)
Orphenadrine citrate Is a éther false Inferred relationship Existential restriction modifier (core metadata concept)
Orphenadrine citrate Is a Substance with ether structure (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Orphenadrine citrate adverse reaction Causative agent (attribute) True Orphenadrine citrate Inferred relationship Existential restriction modifier (core metadata concept) 1
Orphenadrine citrate allergy Causative agent (attribute) False Orphenadrine citrate Inferred relationship Existential restriction modifier (core metadata concept)
Orphenadrine citrate 100 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Orphenadrine citrate Inferred relationship Existential restriction modifier (core metadata concept)
Orphenadrine citrate 30mg/mL injection solution ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Orphenadrine citrate Inferred relationship Existential restriction modifier (core metadata concept)
Orphenadrine citrate 100mg m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Orphenadrine citrate Inferred relationship Existential restriction modifier (core metadata concept)
Acetaminophen+orphenadrine citrate 500mg/50mg caplets The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Orphenadrine citrate Inferred relationship Existential restriction modifier (core metadata concept)
Acetaminophen + orphenadrine citrate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Orphenadrine citrate Inferred relationship Existential restriction modifier (core metadata concept)
Orphenadrine citrate (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Orphenadrine citrate Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Orphenadrine citrate Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Orphenadrine citrate Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely aspirin 770 milligram and caffeine 60 milligram and orphenadrine citrate 50 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Orphenadrine citrate Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 856 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Orphenadrine citrate Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin + caffeine + orphenadrine citrate tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Orphenadrine citrate Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin + caffeine + orphenadrine citrate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Orphenadrine citrate Inferred relationship Existential restriction modifier (core metadata concept)
Orphenadrine citrate allergy Causative agent (attribute) False Orphenadrine citrate Inferred relationship Existential restriction modifier (core metadata concept) 1
Orphenadrine citrate 100 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Orphenadrine citrate Inferred relationship Existential restriction modifier (core metadata concept) 1
Orphenadrine citrate 100 mg oral tablet Has basis of strength substance (attribute) True Orphenadrine citrate Inferred relationship Existential restriction modifier (core metadata concept) 1
Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has basis of strength substance (attribute) False Orphenadrine citrate Inferred relationship Existential restriction modifier (core metadata concept) 1
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has basis of strength substance (attribute) False Orphenadrine citrate Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely aspirin 770 milligram and caffeine 60 milligram and orphenadrine citrate 50 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Orphenadrine citrate Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing precisely aspirin 770 milligram and caffeine 60 milligram and orphenadrine citrate 50 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) False Orphenadrine citrate Inferred relationship Existential restriction modifier (core metadata concept) 3
Aspirin 856 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Orphenadrine citrate Inferred relationship Existential restriction modifier (core metadata concept) 3
Aspirin 856 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet Has basis of strength substance (attribute) False Orphenadrine citrate Inferred relationship Existential restriction modifier (core metadata concept) 3
Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Orphenadrine citrate Inferred relationship Existential restriction modifier (core metadata concept) 3
Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has basis of strength substance (attribute) False Orphenadrine citrate Inferred relationship Existential restriction modifier (core metadata concept) 3
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Orphenadrine citrate Inferred relationship Existential restriction modifier (core metadata concept) 3
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has basis of strength substance (attribute) False Orphenadrine citrate Inferred relationship Existential restriction modifier (core metadata concept) 3
Aspirin 856 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet Has basis of strength substance (attribute) True Orphenadrine citrate Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely aspirin 770 milligram and caffeine 60 milligram and orphenadrine citrate 50 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) False Orphenadrine citrate Inferred relationship Existential restriction modifier (core metadata concept) 1
Orphenadrine citrate 100mg prolonged-release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Orphenadrine citrate Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has precise active ingredient False Orphenadrine citrate Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely aspirin 770 milligram and caffeine 60 milligram and orphenadrine citrate 50 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient False Orphenadrine citrate Inferred relationship Existential restriction modifier (core metadata concept) 1
Orphenadrine citrate 100 mg oral tablet Has precise active ingredient True Orphenadrine citrate Inferred relationship Existential restriction modifier (core metadata concept) 1
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has precise active ingredient False Orphenadrine citrate Inferred relationship Existential restriction modifier (core metadata concept) 1
Aspirin 856 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet Has precise active ingredient True Orphenadrine citrate Inferred relationship Existential restriction modifier (core metadata concept) 2
Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has precise active ingredient True Orphenadrine citrate Inferred relationship Existential restriction modifier (core metadata concept) 2
Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has basis of strength substance (attribute) True Orphenadrine citrate Inferred relationship Existential restriction modifier (core metadata concept) 2
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has basis of strength substance (attribute) True Orphenadrine citrate Inferred relationship Existential restriction modifier (core metadata concept) 2
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has precise active ingredient True Orphenadrine citrate Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely aspirin 770 milligram and caffeine 60 milligram and orphenadrine citrate 50 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Orphenadrine citrate Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely aspirin 770 milligram and caffeine 60 milligram and orphenadrine citrate 50 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Orphenadrine citrate Inferred relationship Existential restriction modifier (core metadata concept) 2

This concept is not in any reference sets

Back to Start